-
1
المصدر: Personalized Medicine. 16:439-448
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cost effectiveness, medicine.medical_treatment, Olaparib, 03 medical and health sciences, chemistry.chemical_compound, Brca1 2 mutation, 0302 clinical medicine, Breast cancer, Internal medicine, medicine, Profiling (information science), In patient, 030212 general & internal medicine, skin and connective tissue diseases, health care economics and organizations, Pharmacology, Chemotherapy, business.industry, General Medicine, medicine.disease, Metastatic breast cancer, chemistry, 030220 oncology & carcinogenesis, Molecular Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3d790dc0e61b11e401127522e7cea8cdTest
https://doi.org/10.2217/pme-2018-0141Test -
2
المؤلفون: Masayuki Nagahashi, Harry D. Bear, Kazuaki Takabe, Akimitsu Yamada, Subramaniam Ramachandran, Christina Stevenson
المصدر: Future Oncology. 8:403-414
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, Angiogenesis, Angiogenesis Inhibitors, Antineoplastic Agents, Breast Neoplasms, Disease, Antibodies, Monoclonal, Humanized, Article, Breast cancer, Internal medicine, medicine, Animals, Humans, Clinical Trials as Topic, Neovascularization, Pathologic, business.industry, Cancer, General Medicine, medicine.disease, Lymphangiogenesis, Clinical trial, Monoclonal, Disease Progression, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71ddc94689b9caaa520b990ca0dbf6bbTest
https://doi.org/10.2217/fon.12.22Test